Geke M Overvliet1,2, Rebecca A C Jansen1, Anton J L M van Balkom3, Dilene C van Campen4, Mardien L Oudega1, Ysbrand D van der Werf4, Eric van Exel1, Odile A van den Heuvel4,5, Annemiek Dols1,2. 1. Department of Old Age Psychiatry, GGZ inGeest, Specialized Mental Health Care, Amsterdam, Netherlands. 2. Department of Neurology, Amsterdam UMC, location VUmc, Amsterdam Neuroscience, Amsterdam, Netherlands. 3. GGZ inGeest Specialized Mental Health Care, Amsterdam, Netherlands. 4. Department of Anatomy & Neurosciences, Amsterdam UMC, location VUmc, Amsterdam Neuroscience, Amsterdam, Netherlands. 5. Department of Psychiatry, Amsterdam UMC, location VUmc, Amsterdam Neuroscience, Amsterdam, Netherlands.
Abstract
OBJECTIVE: In the last decade, repetitive transcranial magnetic stimulation (rTMS) has been introduced as a non-invasive neuromodulation therapy for depression. Little is known, however, about (serious) adverse events (AE) of rTMS in older adults with a depression. In this article, we want to study what is known about (serious) AE of rTMS in older adults (>60 years) with late-life depression (LLD). METHODS: A systematic search has been performed according to the PRISMA guidelines in PubMed, EMBase and PsycInfo. We have screened 622 articles for eligibility. Eleven studies, evaluating 353 patients in total, were included in this review. RESULTS: AE were reported in 12.4% of the older adults with a LLD treated with rTMS, serious AE in 1.5%. Headache (6.9%) and discomfort at the stimulation site (2.7%) are the most commonly reported AE. Serious AE reported are: psychiatric hospitalization (three times), a combination of posterior vitreous detachment and retinal tear, and increased suicide ideation (both once). CONCLUSIONS: rTMS in older adults with LLD was concluded overall to be safe due to the low frequency of AE reported in trials and observational studies. In case-reports, however, more serious AE have been described. To tailor use of rTMS in older adults with LLD, more research is needed in larger samples to optimize tolerance.
OBJECTIVE: In the last decade, repetitive transcranial magnetic stimulation (rTMS) has been introduced as a non-invasive neuromodulation therapy for depression. Little is known, however, about (serious) adverse events (AE) of rTMS in older adults with a depression. In this article, we want to study what is known about (serious) AE of rTMS in older adults (>60 years) with late-life depression (LLD). METHODS: A systematic search has been performed according to the PRISMA guidelines in PubMed, EMBase and PsycInfo. We have screened 622 articles for eligibility. Eleven studies, evaluating 353 patients in total, were included in this review. RESULTS: AE were reported in 12.4% of the older adults with a LLD treated with rTMS, serious AE in 1.5%. Headache (6.9%) and discomfort at the stimulation site (2.7%) are the most commonly reported AE. Serious AE reported are: psychiatric hospitalization (three times), a combination of posterior vitreous detachment and retinal tear, and increased suicide ideation (both once). CONCLUSIONS: rTMS in older adults with LLD was concluded overall to be safe due to the low frequency of AE reported in trials and observational studies. In case-reports, however, more serious AE have been described. To tailor use of rTMS in older adults with LLD, more research is needed in larger samples to optimize tolerance.
Authors: Alexandre Dardenne; Chris Baeken; Cleo L Crunelle; Chris Bervoets; Frieda Matthys; Sarah C Herremans Journal: Brain Stimul Date: 2017-10-31 Impact factor: 8.955
Authors: Deborah C.W. Klooster; Iris N. Vos; Karen Caeyenberghs; Alexander Leemans; Szabolcs David; René M.H. Besseling; Albert P. Aldenkamp; Chris Baeken Journal: J Psychiatry Neurosci Date: 2020-07-01 Impact factor: 6.186
Authors: A Suppa; Y-Z Huang; K Funke; M C Ridding; B Cheeran; V Di Lazzaro; U Ziemann; J C Rothwell Journal: Brain Stimul Date: 2016-01-27 Impact factor: 8.955
Authors: Hannie C Comijs; Harm W van Marwijk; Roos C van der Mast; Paul Naarding; Richard C Oude Voshaar; Aartjan Tf Beekman; Marjolein Boshuisen; Janny Dekker; Rob Kok; Margot Wm de Waal; Brenda Wjh Penninx; Max L Stek; Johannes H Smit Journal: BMC Res Notes Date: 2011-12-05